FDA Inspection 651880 — Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc. — FEI 1420913

The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on March 24, 2010 in Morton Grove, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 24, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morton Grove, IL (United States)

Citations

IDCFRDescription
183321 CFR 211.84(d)(1)Identity Testing of Each Component
192021 CFR 211.166(a)(3)Valid stability test methods
241921 CFR 211.198(a)Complaint Handling Procedure